Viewing nowActa Zone Tablets (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
IQURE Co., Ltd.

MFDS item code 201601149 · Approved 2016.02.29 · Insurance code 674400650
Improvement of Type 2 Diabetes (blood sugar control)
This medication is used to improve blood sugar control in patients with Type 2 diabetes. It supports dietary and exercise therapies and can also be administered as monotherapy. If the patient does not respond to other oral hypoglycemic agents, it can be combined with sulfonylureas, metformin, or insulin. Additionally, it is important for patients to engage in nutritional counseling, weight loss, and regular exercise therapy. These treatment methods can help maintain drug efficacy as well as initial treatment. This medication is used for blood sugar improvement and diabetes management.
This medication is taken orally once daily, regardless of meals. 1. Monotherapy It can be started at 15 mg once daily for patients whose blood sugar is not adequately controlled. If sufficient effect is not observed, the dosage may be increased to 30 mg once daily. 2. Combination therapy - When combined with sulfonylureas, the initial dose should be 15 mg once daily. - When combined with metformin, the initial dose should be 15 mg once daily.
Experience in patients under 18 years of age is lacking, so its use is not recommended.
This medication is used for the treatment of Type 2 diabetes and helps control blood sugar levels by improving insulin sensitivity. Careful monitoring is advised for patients with heart failure, as symptoms may worsen. It should not be administered to patients with heart failure or a history of heart failure. During treatment, signs of heart failure such as changes in weight, shortness of breath, and edema should be closely observed; if these symptoms occur, the patient should consult a doctor immediately. Furthermore, this medication can cause fluid retention, which may exacerbate heart failure, so patients with edema should exercise particular caution. This medication should not be used in patients with active bladder cancer or a history of bladder cancer; any symptoms of hematuria or urinary disturbances during treatment should be reported to healthcare professionals immediately. It is also not safe for patients with compromised liver function or severe renal impairment to take this medication. Women who are pregnant or may become pregnant should not take this medication, and premenopausal women should use appropriate contraceptive measures, as this medication may enhance ovulation. There is an increased risk of hypoglycemia when this medication is combined with other diabetes medications, so dosage adjustments may be necessary. Regular blood sugar and liver function tests are important during treatment, and if abnormal symptoms occur, immediate consultation with a doctor is crucial. In cases of overdose, no specific symptoms may be present, but appropriate treatment should be provided based on symptoms. This medication has not been proven safe or effective for children, and caution should be used when administering it to the elderly. Finally, this medication should be stored in its original container and kept out of reach of children.
Congestive heart failure, edema (including severe swelling), urinary abnormalities, urticaria, severe allergic reactions, liver abnormalities (jaundice), severe skin reactions, serious neurological symptoms, high fever with severe rash, blisters, skin peeling, oral/ocular mucosal pain, difficulty breathing, asthma attacks, respiratory difficulties accompanying cough and fever, significant decrease in urine output, systemic swelling, elevated blood pressure, liver failure, stroke, myocardial infarction, cardiac dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container protected from light and air, and should not be kept in places with high humidity. The optimal storage temperature is between 15 degrees and 30 degrees Celsius, ideally around 25 degrees Celsius.
White round tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
IQURE Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.